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Abstract 
Applying the sweat-test as the first choice of test when a diagnosis of cystic fibrosis is suspected is still common 
practice and advisable. Since the cloning of the CFTR gene more than 400 different cystic fibrosis (CF) mutations 
have already been identified. The use of CF mutation analysis for diagnostic purposes in CF has therefore remained 
elusive so far. It is advised to perform sweat-tests as previously described by Gibson and Cooke. In this study we 
have re-evaluated the results of sweat-tests of 1905 subjects performed in our hospital over a period of 9 years 
(1983-1992). In 1825 subjects where the CF diagnosis was not made, the mean sodium value obtained was 15.5 & 9.2 
mmol/l. The upper lim it of the normal range (2 SD above the mean) is 34 mmol/l. Re-examination of all 239 sweat 
sodium values (80.9 i- 19.5 mmol/l) in 80 newly diagnosed CF patients (all: Na+> 70 mmol/l) revealed that 5% of 
the values were below SO mmol/l, the lowest sweat value obtained being 27 mmol/l. Based on these results, we 
recommend in case of clinical suspicion of CF and sweat values above 30 mmol/l to repeat the sweat-test and to 
determine both sodium and chloride for optimal discrimination. 
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1. Introduction 
Classically, the diagnosis of cystic fibrosis (CF) 
is based on the high salt content in sweat due to a 
defect in reabsorbing chloride of the sweat duct 
[l]. The CF transmembrane conductance regula- 
tor may be held responsible for the defective 
chloride transport [2]. Since the cloning of the 
CFTR gene [3], more than 400 different cystic 
fibrosis (CF) mutations have already been identi- 
fied. The use of CF mutation analysis for diag- 
nostic purposes in CF has therefore remained 
elusive so far. In our centre (112 paediatric and 
57 adult genotyped patients) no CF mutation was 
identified in 2.4% of patients while in 21.9% only 
one mutation could be found. Of all chromo- 
somes tested, the mutations found are given in 
Table 1. 
2. Clinical presentatim of cystic flbrtwis 
Applying the sweat-test as a diagnostic proce- 
dure for CF originates from the clinical suspicion 
of the disease. It is thus crucial to have knowl- 
edge of the presenting symptoms of CF. In our 
hospital (118 paediatric CF patients) 68.6% were 
diagnosed within the first year of life. Twenty-six 
(22%) presented with meconium ileus while in all 
cases of meconium ileus studied in the last few 
years, 42 out of 54 (77.8%) appeared to have CF. 
Although the presence of meconium ileus is very 
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suspicious of CF, it is not specific for this disease 
[4]. In 21% of the patients the mode of presenta- 
tion was related to other intestinal manifestations 
such as steatorrhoea or failure to grow. In 19% 
respiratory symptoms raised the clinical suspicion 
of CF (chronic sinusitis, nasal polyps, chronic 
cough, recurrent lower airway infections, suspect 
sputum cultures with Staphylococcus aureus and 
Pseudomonas aeruginosa, or abnormal X-ray find- 
ings suggestive of bronchiectasis). Furthermore, 
respiratory as well as intestinal symptoms were 
present in 16.1% of patients. Finally, 8.5% of 
patients were detected due to a positive family 
history. 
3. The sweat-test 
For reliable sweat-testing it is advisable to use 
only the method as previously described by Gib- 
son and Cooke [5]. Carefully wash the skin area 
with distilled water. Pilocarpine iontophoresis 
should be applied for 5 (max. 10) m in. Use filter 
paper, cup or capillary tube for collection during 
1 h. Determination should be performed of both 
chloride and sodium. It is advised that the amount 
of sweat produced is more than 100 mg. In our 
hospital (now > 400 tests yearly) false results due 
to a small production were not found when at 
least 30 mg of sweat is produced. However, we 
still advise to await a test result with more than 
50 mg of sweat. It is important to perform the 
Table 1 
CF mutations found in CF Center Rotterdam (118 paediatric 
and 68 adult patients) 
CF mutations %  of 338 chromosomes 
tested 
dF508 
A445E 
1717 1G + A 
G542X 
N1303K 
R553X 
L927P 
dL1260 
R1162X 
1078delT 
73.3 
4.1 
2.7 
2.1 
0.9 
0.9 
0.9 
0.6 
0.3 
0.3 
0.3 
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Fig. 1. All sweat sodium values of the first (adequately per- 
formed) sweat-test in the period from January 1983 to May 
1992. In 1825 subjects (open bars) where the CF diagnosis was 
not made, the mean sweat-test result was 15.5 + 9.2 mmol/l. 
From these subjects 144 had a first sweat sodium of more 
than 30 mmol/l in which the CF diagnosis may well be 
reconsidered. The mean of the first sweat-test results in 80 
diagnosed CF patients (filled bars) was 83.7+ 17.2 mmol/l. 
All CF patients fulfilled our previously used criterion of a 
positive sweat-test ( > 70 mmol/l;vertical line). In addition, 
the variation of all 239 sweat sodium values in the 80 CF 
patients was considerable (stippled bars); 5% were below 50 
mmol/l, and the lowest sweat value obtained was 27 mmol/l. 
diagnostic sweat-test beyond the age of 6 weeks 
since early tests may give a false-positive result. 
This is due to the physiological low sodium reab- 
sorption at young age. Here, a false-positive re- 
sult may be suggested from the higher sodium 
content of the sweat compared to chloride. 
To be conclusive, a positive test result (chlo- 
ride above 60 mmol/l or sodium above 70 
mmol/l) should be obtained on two separate 
occasions. Sweat chloride levels provide a better 
discrimination between normal persons and CF 
patients than do sodium levels [6-81. Using the 
above-mentioned criteria for a CF diagnosis, 
sweat-test results of some CF patients may be 
within the “normal” range [9,10]. In the following 
study an attempt was made to unravel the ques- 
tion of what really can be defined as the normal 
result of the sweat-test. 
We re-examined all sweat-test results in the 
period from January 1983 to May 1992. Chloride 
measurements were not routinely performed in 
this period. From each of the 1905 subjects the 
result of the first adequately performed sweat-test 
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was used. These data were stratified for the 
known 80 CF patients diagnosed in this period. 
In 1825 subjects where the CF diagnosis was not 
made the mean sodium value obtained was 15.5 
-t 9.2 mrnol/l. The upper limit of the normal 
range (2 SD above the mean) is 34 mmol/l. All 
80 CF patients fulfilled our previous criterion of a 
positive sweat-test result (Na+> 70 mmol/l). In 
addition, to investigate the variability of the 
sweat-test from the 80 CF patients all their 239 
sweat-test results were obtained (Na+ 80.9 it 19.5 
mmol/l). Five percent -of the values were below 
50 mmol/l and the lowest sweat value obtained 
was 27 mmol/l. This demonstrates that a CF 
diagnosis may not be excluded when sweat sodium 
is just around 30 mmol/l. 
4. Intestinal current measurement 
Studying intestinal current measurements 
(ICM) in rectal biopsies of CF patients [HI, the 
magnitude of the chloride current (largely deter- 
mined by the CF genotype) was found to corre- 
late with the clinical phenotype [12]. Using the 
same technique for diagnostic purposes [131 re- 
vealed that it is very likely that CF can be diag- 
nosed with ICM in those patients whose sweat 
sodium values are just above 30 mmol/l. Until 
now ICM has proved to be highly sensitive and 
specific since chloride channel and sodium chan- 
nel activity can be studied separately. The sweat- 
test in itself is not very specific for CF since low 
sodium reabsorption (as found in several en- 
docrinopathies) may also cause an abnormal re- 
sult. Elevated sweat-tests (even with chloride in 
excess of sodium) may also be found in known CF 
carriers. Diagnostic evaluation of these carriers 
can be troublesome since they may well have one 
detectable CF mutation as do most “borderline” 
CF patients. Since sweat values tend to rise with 
age, difficulties in the interpretation of the test 
can also be found in adults. It is our experience 
that ICM is especially of value in these situations. 
5. Different phenotypes of CF and their genotypes 
Another fact pointing in the direction that the 
CF incidence may be higher than we presently 
presume, derives from the knowledge of males 
with congenital bilateral absence of vas deferens 
(CBAVD). This is likely to be a genital form of 
CF although some of these males may also suffer 
from other CF manifestations 114,151. In males 
with CBAVD approximately 12% carry a R117H 
mutation [1.5]. This is suspected to be a CF muta- 
tion, occurring very rarely in CF patients. From 
Table 1 it can also be suggested that not all CF 
patients are recognized: The number of dF508 
chromosomes found in CF patients (73.3%) is less 
than expected (77.3%) from the number of dF.508 
homozygous patients (59.8%). 
6. Conclusion 
It is strongly advised to change the lower limit 
of a borderline sweat-test from 50 to 30 mmol/l. 
Repeated, well-performed sweat-tests and in se- 
lected cases additional tests (i.e. CF mutation 
analysis, ICM, nasal PD measurements, CFTR 
antibodies) may be of help in the CF diagnosis. 
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